Famotidine represents a histamine H2-receptor antagonist, effectively inhibiting the secretion of gastric acid. This action reduces the symptoms of various gastrointestinal disorders, comprising peptic ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. Famotidine's therapeutic profile demonstrates a relatively long half